US 6333313
Clinical use of oxytocin alone or in combination to treat bone disorders
expired A61KA61K38/095
Quick answer
US patent 6333313 (Clinical use of oxytocin alone or in combination to treat bone disorders) held by The Board of Regents of the University of Texas System expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/095